Related Experiment Video
Updated: May 20, 2026
09:38
Direct Reprogramming of Mouse Fibroblasts into Melanocytes
Published on: August 27, 2021
Vitiligo: an update on current pharmacotherapy and future directions
Roberta Colucci1, Torello Lotti, Silvia Moretti
1University of Florence, Section of Clinical, Preventive and Oncologic Dermatology, Department of Critical Care Medicine and Surgery, Florence, Italy. roberta.colucci21@gmail.com
Expert Opinion on Pharmacotherapy
|July 28, 2012
Summary
Vitiligo treatment can achieve satisfactory repigmentation using first-line therapies like topical corticosteroids and phototherapy. Second-line options include vitamin D analogues and surgery for challenging vitiligo cases.
Area of Science:
- Dermatology
- Immunology
Background:
- Vitiligo is a prevalent skin condition causing white patches.
- Effective treatment for vitiligo remains a significant clinical challenge.
Purpose of the Study:
- To review current first- and second-line pharmacological treatments for vitiligo.
- To discuss mechanisms, indications, efficacy, and side effects of vitiligo therapies.
- To provide an overview of non-pharmacological and future treatment directions.
Main Methods:
- Comprehensive review of pharmacological treatments for vitiligo.
- Analysis of mechanisms of action, indications, efficacy, and side effects.
- Inclusion of non-pharmacological options like phototherapy and surgery.
Main Results:
- Topical corticosteroids, calcineurin inhibitors, phototherapy, and photochemotherapy are effective first-line treatments.
- Vitamin D analogues, targeted phototherapy, oral corticosteroids, and surgery are viable second-line options.
- Antioxidants can supplement other treatments, while depigmenting agents are for extensive cases.
Conclusions:
- Satisfactory and stable repigmentation of vitiligo is achievable.
- First-line therapies offer safety and efficacy for vitiligo management.
- Tailored treatment strategies, including second-line and adjunctive therapies, are crucial for vitiligo patients.
Related Concept Videos
01:14Changes in Skin Color: Clinical Perspectives
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...